Ipamorelin
Add 2 more to unlock 17% off
As of 2026-06-08, DMV Research publishes 1 third-party certificate of analysis for Ipamorelin (CAS 170851-70-4), for laboratory research use only.
Selective growth hormone secretagogue for GH research.
All products currently listed on this site are for research purposes only. Research use only — not for human or veterinary use.
For laboratory research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use. Not a drug, food, cosmetic, or dietary supplement.
For in-vitro and pre-clinical research use only. Not for human consumption, therapeutic use, or veterinary application. Research Use Only Policy
Text or call (571) 992-4721 or email info@dmvresearch.shop — real people, real fast.
Reach the business line directly at (571) 992-4721.
Tracked shipping
Tracking emailed when it ships
Damaged on arrival?
Replaced free if reported within 48 hours
Secure checkout
256-bit SSL
Certificate of Analysis Report
Third-party HPLC purity testing for this compound by an independent laboratory. Download the full-resolution reports below.
Independently HPLC-tested for identity, purity, and concentration.
Compound Information
Updated 2026-06-08Technical specifications
A selective ghrelin-receptor (GHS-R1a) agonist and pentapeptide growth-hormone secretagogue. Distinguished in research for its selectivity profile — minimal cortisol or prolactin response compared to other secretagogues.
What Is Ipamorelin?
- Type
- Synthetic Pentapeptide (GHS-R1a Agonist)
- CAS Number
- 170851-70-4
- Molecular Weight
- 711.9 g/mol
- Molecular Formula
- C₃₈H₄₉N₉O₅
- Amino Acids
- 5
- Sequence
- Aib-His-D-2-Nal-D-Phe-Lys-NH₂
- Primary Target
- GHS-R1a (ghrelin receptor)
Stability Information
Lyophilized (powder)
-20°C· stable
GHS-R1a Selective Agonism
GH secretagogue without ACTH/cortisol response
Research Outcomes
Sources & References
7 sources · research references
European Journal of Endocrinology
Ipamorelin, the First Selective Growth Hormone Secretagogue
1998
Raun K, et al.
British Journal of Pharmacology
Pharmacokinetic and Pharmacodynamic Study of Ipamorelin: A New Growth Hormone Releasing Peptide
1999
Johansen PB, Segev Y, Landau D, et al.
Growth Hormone & IGF Research
The Growth Hormone Secretagogue Ipamorelin Counteracts Glucocorticoid-Induced Decrease in Bone Formation
2001
Andersen NB, et al.
Not for human consumption. This product is sold exclusively for research and educational purposes. For laboratory research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use. Not a drug, food, cosmetic, or dietary supplement.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations. See our Research Use Only policy.
